Vanguard Asset Management »

Kura Oncology shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Kura Oncology (KURA) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Kura Oncology

Tip: Access up to 7 years of quarterly data

All positions including Kura Oncology held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kura Oncology by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $416k 51k 8.13

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Kura Oncology

BlackRock
Suvretta Capital Management
BVF
Vanguard Group
State Street Corporation
Vanguard Capital Management
Armistice Capital
Deep Track Capital
Prosight Management
AQR Capital Management
Geode Capital Management
Renaissance Technologies
Millennium Management
Alethea Capital Management
Goldman Sachs Group

View all funds holding Kura Oncology